Head-To-Head Comparison: Lombard Medical (EVAR) vs. The Competition
Lombard Medical (NASDAQ: EVAR) is one of 84 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its rivals? We will compare Lombard Medical to related companies based off the strength of its profitability, dividends, valuation, risk, earnings, institutional ownership and analyst recommendations.
Volatility and Risk
Lombard Medical has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, Lombard Medical’s rivals have a beta of 1.08, meaning that their average stock price is 8% more volatile than the S&P 500.
Institutional & Insider Ownership
40.2% of Lombard Medical shares are owned by institutional investors. Comparatively, 63.4% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 13.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This table compares Lombard Medical and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Lombard Medical Competitors||-128.75%||-37.36%||-10.54%|
This is a summary of recent ratings and target prices for Lombard Medical and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Lombard Medical Competitors||321||1469||2569||105||2.55|
All “Medical Equipment, Supplies & Distribution” companies have a potential upside of 3.83%. Given Lombard Medical’s rivals higher possible upside, analysts clearly believe Lombard Medical has less favorable growth aspects than its rivals.
Valuation & Earnings
This table compares Lombard Medical and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Lombard Medical||$12.17 million||-$24.22 million||-0.29|
|Lombard Medical Competitors||$827.05 million||$159.48 million||33.11|
Lombard Medical’s rivals have higher revenue and earnings than Lombard Medical. Lombard Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently the more affordable than other companies in its industry.
Lombard Medical rivals beat Lombard Medical on 8 of the 9 factors compared.
About Lombard Medical
Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.
Receive News & Ratings for Lombard Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lombard Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.